immunogenicity

GW280264X (Carbamic acid) is an inhibitor of ADAM17 .

Lipopolysaccharides (LPS), derived from Escherichia coli O55:B5, are essential components of the outer membrane of Gram-negative bacteria. Composed of lipid A, a core oligosaccharide, and an O-specific polysaccharide, LPS exhibits strong immunogenicity. It activates immune cells via the TLR4 receptor, induces chemotactic cell migration and cytokine secretion, and helps maintain the integrity of the bacterial outer membrane, protecting against bile salts and lipid-based antibiotics. LPS is commonly used to establish inflammatory models, including arthritis, chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and gastrointestinal disease models.

PEG300 (Polyethylene glycol 300) is a polymer formed from repeating units of ethylene glycol that is water soluble, low immunogenicity, and biocompatible. PEG300 is a neutral polymer with a molecular weight of 300.

PEG400 (Polyethylene glycol 400) is a polymer formed from repeating units of ethylene glycol that is water soluble, low immunogenicity, and biocompatible. PEG400 is a neutral polymer with a molecular weight of 400.

3D-Monophosphoryl Lipid (14) (3D-Monophosphoryl Lipid (14)) triethylamine is a TLR agonist that serves as an adjuvant in vaccines to enhance their immunogenicity.

3D-Monophosphoryl Lipid (12,16) (triethylamine) serves as a Toll-like Receptor (TLR) agonist and is used as an adjuvant in vaccines to enhance their immunogenicity.

3D-Monophosphoryl Lipid (14) (ammonium) acts as a TLR agonist and serves as an adjuvant for vaccines, enhancing their immunogenicity.

3D-Monophosphoryl Lipid A-5 (free acid) is a TLR agonist used as an adjuvant in vaccines to enhance their immunogenicity.

3D-Monophosphoryl Lipid A-5 (3D-MPLA-5) triethylamine is a TLR agonist that acts as an adjuvant for vaccines, enhancing their immunogenicity.

Dihydrotestosterone-KLH is a hapten-carrier protein conjugate formed by coupling Dihydrotestosterone (DHT) to keyhole limpet hemocyanin (KLH). As a hapten, Diethylstilbestrol alone cannot induce an immune response and must be conjugated to a large molecular protein to become a complete antigen with immunogenicity. Dihydrotestosterone-KLH may be supplied as a lyophilized powder or as a solution. The solution is prepared in 0.01 M TBS (pH 7.4) buffer at a typical concentration of 1 mg/mL.

3D-Monophosphoryl Lipid (12,16) (3D-MPL (12,16)) free acid is a TLR agonist that serves as a vaccine adjuvant to boost the immunogenicity of vaccines.

LNS8801 is an orally active agonist of the G protein-coupled estrogen receptor (GPER). By activating GPER, LNS8801 mediates downstream signaling pathways, such as promoting cAMP production and activating CREB signaling, which results in antitumor activities like inhibiting tumor cell proliferation, inducing cell differentiation, and enhancing tumor immunogenicity. It is applicable in research across various cancers, such as melanoma, pancreatic cancer, colorectal cancer, and lung cancer, as well as studies exploring the role of GPER in normal physiological and pathological processes.

PDIC-NN dimethanesulfonate (PDIC-NS) is a STING activator with anticancer properties. It increases the levels and stability of endogenous cyclic dinucleotides (CDN). PDIC-NN dimethanesulfonate triggers a burst of reactive oxygen species (ROS) and causes significant mitochondrial damage. It induces apoptosis and inhibits DNA replication. Additionally, it activates the cGAS-STING signaling pathway, enhancing the immunogenicity of tumor cells and triggering a strong innate immune response.

OART (Oxaliplatin-artesunate) is a ferroptosis inducer that significantly inhibits tumor cell proliferation. It promotes tumor ferroptosis by disrupting the glutathione-mediated ferroptosis defense system and enhancing the iron-dependent Fenton reaction, leading to lipid peroxidation in the cytoplasm and mitochondria. Additionally, OART increases tumor immunogenicity, transforming the tumor environment from immunosuppressive to immunosensitive. It exhibits strong tumor regression effects in tumor-bearing mouse models and can be utilized in cancer immunotherapy research.

VR11 aptamer is a DNA-based TNF-α inhibitor with a KD of 7.0 nM. It effectively blocks TNFα-induced apoptosis (apoptosis) and prevents NO production. VR11 aptamer demonstrates no immunogenicity as it does not trigger an immune response when administered intraperitoneally in C57BL/6 mouse models. This aptamer is suitable for research on inflammatory diseases.

1,2-Dipalmitoyl-13C-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1,2-dipalmitoyl-sn-glycero-3-PC by GC- or LC-MS. 1,2-Dipalmitoyl-sn-glycero-3-PC (T7773) (DPPC) is a zwitterionic glycerophospholipid commonly used in the formation of lipid monolayers, bilayers, and liposomes for use in a variety of applications.1,2,3,4 It has been used in the formation of proteoliposomes for implantation of γ-glutamyl transpeptidase into human erythrocyte membranes.3 Incorporation of glycosphingolipid antigens into DPPC-containing liposomes increases the immunogenicity of the antigens in mice.4

Fondaparinux sodium (Arixtra, SR-90107A) is a synthetic heparin anticoagulant and an antithrombin-dependent factor Xa inhibitor (IC50=1909 nM), with high selectivity, low immunogenicity, and favorable pharmacokinetic properties, used for the prevention and treatment of thrombotic diseases.

Lipopolysaccharides from Escherichia coli O111:B4 are key components of the outer membrane of Gram-negative bacteria. As a smooth-type LPS, they consist of lipid A, an R3-type core oligosaccharide, and an O-specific polysaccharide. These LPS molecules exhibit high immunogenicity, can trigger strong immune responses and gastric disorders by activating the TLR-4 receptor on immune cells, and help maintain the structural integrity of the bacterial outer membrane while protecting against bile salts and lipid-based antibiotics. They are widely used to establish inflammation-related disease models, such as chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS).

N1-Methylpseudouridine-5'-triphosphate is a modified nucleotide derivative commonly used to explore RNA modification, synthesis, and function, and can replace UTP in synthesis thereby improving RNA stability and reducing immunogenicity.

N1-Methylpseudouridine-5′-triphosphate tetralithium, also known as 1-Methylpseudouridine-5′-triphosphate tetralithium, is a nucleobase-modified nucleotide. It is utilized in the synthesis of mRNA to decrease immunogenicity and enhance stability [1].

Pseudouridine-5'-triphosphate (Pseudo-UTP) is widely known for its role in polymerase-mediated RNA synthesis, frequently surpassing uridine in unmodified mRNAs due to improved nuclease stability, immunogenicity, and translational properties.

Vaxfectin is a lipid adjuvant used in the development of protein and peptide vaccines.Vaxfectin promotes vaccine immunogenicity.

MOG (35-55) mouse, rat is a minor component of the central nervous system myelin with high brain specificity and strong immunogenicity. It can induce T and B cell responses, trigger relapsing-remitting neurological disorders with plaque-like demyelination, and is commonly used for inducing experimental autoimmune encephalomyelitis (EAE) models.

Anti-Human IL-17A is a fully human anti- interleukin-17A monoclonal antibody. Anti-Human IL-17A can be used for research in psoriasis pathogenesis [1] .